Abstract
Plasmodium falciparum, the causative agent of malaria, moves by an atypical process called gliding motility. Actomyosin interactions are central to gliding motility. However, the details of these interactions remained elusive until now. Here, we report an atomic structure of the divergent Plasmodium falciparum actomyosin system determined by electron cryomicroscopy at the end of the powerstroke (Rigor state). The structure provides insights into the detailed interactions that are required for the parasite to produce the force and motion required for infectivity. Remarkably, the footprint of the myosin motor on filamentous actin is conserved with respect to higher eukaryotes, despite important variability in the Plasmodium falciparum myosin and actin elements that make up the interface. Comparison with other actomyosin complexes reveals a conserved core interface common to all actomyosin complexes, with an ancillary interface involved in defining the spatial positioning of the motor on actin filaments.
Subject terms: Cryoelectron microscopy, Motor protein function
Plasmodium falciparum moves by an atypical process called gliding motility which comprises of atypical myosin A (PfMyoA) and filaments of the dynamic and divergent PfActin-1 (PfAct1). Here authors present the cryo-EM structure of PfMyoA bound to filamentous PfAct1 stabilized with jasplakinolide and provide insights into the interactions that are required for the parasite to produce the force and motion required for infectivity.
Introduction
Malaria is the deadliest parasitic disease around the world, responsible for a half-million deaths per year1. Plasmodium falciparum (Pf), the causative agent of malaria, is able to develop resistance to most of the treatments available today, creating the need for new therapeutic targets2. Like other Aplicomplexan parasites, P. falciparum moves by an atypical process called gliding motility3. The macromolecular complex necessary for force and motion production is called the glideosome, comprised of an atypical myosin A (PfMyoA) and filaments of the dynamic and divergent PfActin-1 (PfAct1)4. While the role of PfMyoA in the movement of the parasite had been established5, it was only recently shown that PfMyoA is essential for invasion of red blood cells by merozoites, the stage responsible for the symptoms of malaria3. PfMyoA thus represents an efficient pharmaceutical target since blocking its activity would impair both the motile and invasive stages of the parasite6,7.
PfMyoA is a divergent myosin, sharing only 28.66% identity with non-muscle myosin IIc (NM2c). Crystallographic structures of PfMyoA revealed an unforeseen N-term extension of the heavy chain that extends over the N-terminal subdomain surface and that can be phosphorylated on serine 19. Phosphorylation specifically tunes the properties of PfMyoA, which can work in two regimes: phosphorylated PfMyoA moves actin at high speed but has low ensemble force; unphosphorylated PfMyoA produces more force but at the expense of speed6,8. These results led us to consider PfMyoA as a tunable molecular engine that could function optimally either at high speed in highly mobile stages such as sporozoites that need to move at more than 2 µm s−1, or with high force in invasive stages such as merozoites that produce forces of ~40 pN to invade the host cell8. Sequence comparisons indicate that an N-terminal extension is also present in Toxoplasma gondii myosin A (TgMyoA), and phosphomimetics in that region increased in vitro motility speeds, suggesting that the tunable mechanism is likely conserved amongst the phylum of Apicomplexan parasites9.
Actin is one of the most conserved proteins amongst all eukaryotes. Despite being one of the most divergent actins, PfAct1 shows 82% sequence identity with cytoplasmic γ-actin. Given the dynamic nature of PfAct1 filaments, jasplakinolide (JAS), a cycle peptide from the sea sponge Jaspis johnstoni that is able to induce actin polymerization, has to be used to stabilize PfAct1 filaments in structural investigations10,11. Not surprisingly, monomeric and JAS-stabilized filamentous PfAct1 exhibits features similar to mammalian monomeric G-actin and filamentous F-actin10,11. Sequence divergence is primarily located at the binding interface of actin-binding proteins and the nucleotide-binding pocket10–12. Furthermore, the contact sites important for filament formation contain notable sequence deviations, particularly within the DNase-1–binding loop (D-loop) which is essential for polymerization10. These sequence differences result in a critical concentration for assembly (in the absence of JAS) that is an order of magnitude higher than for skeletal muscle actin filaments or JAS-stabilized PfAct113. Moreover, PfAct1 filaments are highly unstable once ATP has been hydrolyzed and readily depolymerize13, likely explaining why these filaments have been difficult to visualize in vivo.
The actomyosin complex is recalcitrant to crystallization. Before 2016, the description of this interface by electron microscopy was limited to 7 Å resolution14–17.The recent improvement in electron cryomicroscopy (cryo-EM) technology and software permitted five mammalian actomyosin structures to be solved at a resolution of better than 5 Å: for human non-muscle myosin 2c (NM2c) in the Rigor state at 3.9 Å resolution18; for porcine myosin VI (Myo6) in the Rigor state (4.6 Å)19; and for rat myosin-Ib (myo1b) in the Rigor (3.9 Å) and in two strong binding ADP (3.3 Å and 3.8 Å) states20. All these structures correspond to the states of the motor populated after force generation: the strong ADP state before ADP release, and the nucleotide-free (Rigor) state that have the highest affinity for actin filaments (F-actin) for most myosins. Because the myosin structural elements that bind F-actin are highly divergent in sequence, the actomyosin interface was assumed to vary substantially among myosin motors and is considered hard to predict19. This divergence explains why, despite the fact that several structures are available at high-resolution, the structural features underlying F-actin recognition by myosin are still highly debated. A better knowledge of the actomyosin interface is crucial to understand which parts of the interface are general features, i.e. common to all myosins, and which ones are specific to a particular myosin. In addition, which parts of the interface are attributable to define a specific cellular function is currently unknown.
To understand the mechanism underlying force production by an atypical actomyosin complex and how this interaction differs from previously described recognition of F-actin by mammalian myosins21, we determined the cryo-EM structure of PfMyoA bound to filamentous PfAct1 stabilized with JAS. Using likelihood-based reconstruction of helical specimens and a real-space modeling approach aided by molecular dynamics for the refinement of the model, we present a structure at a resolution of 3.8 Å. The PfActomyosin interface highlights the conserved features that provide the structural basis for the ability of PfMyoA to move both PfAct1 and mammalian actin filaments at similar speeds. Moreover, comparison of this interface with the mammalian ones described previously allows us to subdivide the actomyosin interface into two regions: (i) the conserved core interface that governs filament recognition for all myosins and (ii) the variable ancillary interface that defines the orientation of the motor on the track and tunes specific motor functions.
Results
High-resolution structure of the PfAct1/PfMyoA complex in the Rigor state
Unlike canonical skeletal muscle actin, PfAct1 filaments are dynamic and require a very high critical concentration (~4 µM) to polymerize13. Addition of JAS stabilizes PfAct1 filament dynamics and decreases the critical concentration to the nanomolar range11, which minimizes the presence of actin monomers in the background of cryo-EM preparations10–12,22. Indeed, a 3.8-Å structure of JAS-stabilized PfAct1 filaments has been reported8, while a reconstruction of unstabilized PfAct1 filaments has yet to be accomplished.
To identify experimental conditions for high-resolution structure determination of the Plasmodium falciparum actomyosin complex, various PfMyoA constructs were used, including the full-length protein and the motor domain. However, only sparse and non-cooperative binding to both rabbit skeletal and JAS-stabilized PfAct1 filaments was observed for all pairs. This lack of cooperativity contrasts with the highly cooperative nature of essentially all other previously reported myosin motors binding to actin filaments, which appear either fully decorated or as bare filament stretches in the same field of view in cryo-EM preparations, significantly assisting in particle selection and image processing. Actin-activated ATPase assays showed that the phosphomimetic mutation T417D located in the hypertrophic cardiomyopathy (HCM) loop of the PfMyoA heavy chain (at the TEDS site)23 resulted in a ~3-fold enhancement in actin binding affinity while Vmax is unchanged24. The use of a PfMyoA motor-domain construct with a T417D mutation increased occupancy of binding to JAS-stabilized PfAct1 filaments in cryo-EM preparations (Fig. 1a), although even with the improved occupancy, PfMyoA binding remains sparse (Fig. 1b).
Using these conditions, cryo-EM and Bayesian analysis of helical specimens25 were employed to determine a 3.8 Å cryo-EM reconstruction of the complex (Fig. 1c, Supplementary Fig. 1). The reconstruction shows the converter in the post power-stroke position, similar to the position obtained for actin bound myosin II in the Rigor state18. Using the atomic models of the PfAct111 and PfMyoA in the Rigor-like state8 as starting points, we were able to accurately place the protein chains throughout most of the density map and, in regions with higher resolution, to confidently discriminate and place side chains (statistics in Supplementary Table 1).
Regions of the motor further away from the PfAct1 filament such as the Converter and a part of the N-terminal PfMyoA subdomain are less well defined (Fig. 1d) in the reconstruction but this is readily explained by increased atomic temperature factors in those regions (Fig. 1e). In fact, the model displays a characteristic repartition of the atomic temperature factors: the lowest atomic temperature factors are located close to the PfAct1/PfMyoA interface for the two motor subdomains (Upper-50 kDa and Lower-50 kDa) involved in binding the PfAct1 filament. Higher atomic temperature factors are located in the N-terminus (N-term extension and the SH3-like structural domain), the Transducer, the Relay and the Converter. The regions that display the highest atomic temperature factors are located in the Converter. This suggests a certain flexibility of the Rigor conformation of PfMyoA in this region, as previously observed for other actomyosin reconstructions17. Actin and the actomyosin interface are well defined in the electron density (Fig. 1f–i). The tip of Loop2 (residues 632-635) is partially disordered (Fig. 2h), but the interactions with actin are visualized without ambiguity.
Rigor complex formation occurs with only minor conformational changes to PfMyoA
Despite the availability of several high-resolution cryo-EM studies18–20, one of the most debated points has been the conformational changes induced by the formation of the actomyosin assembly both in the actin filament and in the myosin motor. The PfMyoA motor bound to the PfAct1 filament closely resembles the crystal structure of the Rigor-like conformation8 with overall root-mean-square displacement (rmsd) of 0.84 Å. (Fig. 2a, b), There is no electron density at the active site of PfMyoA in this reconstruction that can be attributed to a nucleotide (Fig. 2c). This structure thus represents the Rigor state at the end of the powerstroke in which no nucleotide is bound to the motor domain and, like Rigor structures of other myosins, PfMyoA adopts an inner cleft closure in this state (Fig. 2d). The degree of cleft closure for the Rigor state of PfMyoA is similar to that of the Rigor states of other myosins18–20.
Not surprisingly, some actin-binding elements, namely the HCM-loop (407–430) and Loop4 (363–387) differ in conformation between the PfAct1-bound Rigor and Rigor-like crystal structures of PfMyoA. Note that these two actin-binding elements are quite flexible for the unbound motor but become restrained when myosin binds actin (Fig. 2b). As in the Rigor-like crystal structure, the Rigor conformation of the PfMyoA motor is stabilized by a number of atypical interactions involving several elements implicated in mechanical communication during the power stroke as well as the PfMyoA specific N-terminal extension, which is a key element of the unique tunable mechanism of force-production of PfMyoA via its phosphorylation state8.
Complex formation does not shift the D-loop of PfAct1 but increases the helical twist
The binding of PfMyoA to the PfAct1 filament also does not induce major changes in the conformation of the PfAct1 filament. The structures of the bare11 and decorated PfAct1 filaments superimpose with an rmsd of 0.67 Å (Fig. 3a). Within the interface, only the D-loop shows some modest changes (~1.4 Å maximum between Cα positions) for residues 51–55 that interact with PfMyoA. Notably, the re-orientation of the side chain of E51 is required to avoid a steric clash with myosin (Fig. 3b).
The helical parameters are changed slightly from the unbound PfAct1 filament with an essentially identical subunit rise of 27.3 Å and a helical twist of −168.1°, a change in twist from unbound PfAct1 filaments (−167.5°)11 by 0.6°, a change similar to that observed for actin binding of human myosin 2 C and chicken myosin V18,26. Despite this change in helical twist, neither the intra- and inter-strand interactions nor the specific polar bonds established by the plug are visibly altered in the decorated structure (Fig. 3c). Thus, as in the unbound structure11, these interfaces are generally conserved with those in canonical actin and the key differences explaining the intrinsically decreased stability of PfAct1 filaments11, are still present in the PfMyoA bound filament.
There is a substantial stabilization of PfAct1 when comparing the normalized relative atomic temperature factor distributions of decorated and undecorated PfAct1 in the interface region (Fig. 3d). Surprisingly, the D-loop is the only part of the interface that does not show relative stabilization. The D-loop is one of the few regions that differ in structure in the PfAct1 filament compared with canonical actin. The conformations of the PfAct1 D-loop in the bare or PfMyoA decorated structures are both shifted outward by about 1–2 Å in relation to that of canonical F-actin11. The JAS peptide (Fig. 3e) and the ADP nucleotide (Supplementary Fig. 2) are seen without ambiguity in the electron density at the same positions as in the undecorated filament.
It appears that the PfAct1 D-loop conformation is less sensitive to additional factors binding to the filament than mammalian D-loops. For example, JAS stabilization of rabbit skeletal actin filaments induces an open conformation of the D-loop27,28, while JAS-stabilized PfAct1 filaments adopt the closed conformation that most high-resolution structures of canonical actin filament structures adopt11,27,29,30. Similarly, binding of NM2c and Myo6 induces a shift in the D-loop position towards myosin in the corresponding actin subunit18,19 while there is no perceivable shift in the PfAct1 D-loop upon PfMyoA binding. Sequence differences between PfAct1 and canonical actin substantially alter the intra-strand interface and the conformation of the D-loop. While in canonical F-actin, Q50 plays a critical role by forming a N-H…π bond with Y17029, the equivalent residue in PfAct1 is glutamate E49 that adopts an opposite orientation.
This polymorphism could also explain why the open conformation is not observed in JAS-stabilized PfAct1 filaments, although it would be compatible with the PfMyoA motor domain positioning when bound to PfAct1. The open conformation results from a sharp bend that occurs in the D-loop at residue Q43. Because the equivalent residue is proline P42 in PfAct1, the conformation of the D-loop is restricted, and the open conformation cannot be explored. The open conformation of the D-loop in other actins has been proposed to increase the stability of the actin filament27,28,31. The fact that this conformation cannot be adopted by the D-loop of PfAct1 would thus contribute to the instability of PfAct1 filaments.
The actomyosin Rigor interface displays a conserved actin footprint
Among the Rigor structures solved to date at high resolution, Myo1b and NM2c share a similar overall orientation of the motor domain on the filament, while the Myo6 Rigor structure differs significantly in the overall orientation21. Interestingly, comparison with these structures indicates that PfMyoA adopts an overall orientation that is most similar to that of Myo6 (Fig. 4a). Thus, the difference in overall orientation previously observed for Myo6 compared to other motors19 is not related to the motor directionality. This observation raises the question of what dictates the differences in positioning of the motor and what are the exact interactions formed at the actomyosin interface that govern the orientation. Both PfAct1 and PfMyoA diverge significantly from the sequences of their mammalian counterparts, raising the question of whether the Rigor interactions between PfMyoA and PfAct1 differ from those previously described due to sequence adaptation co-evolution.
To study the actomyosin interface in the PfAct1/PfMyoA Rigor structure, the footprint of the myosin on the PfAct1 filament was determined (Fig. 4b, c). Similar to other myosins21 PfMyoA interacts with the filament through five canonical structural elements. These are the HCM-loop (407-430); Loop2 (625-643); Loop3 (566-580); Loop4 (363-387) and the Helix-Turn-Helix (HTH, 540-565). The Activation Loop (A-loop) is also considered a canonical actin binding element and has been reported to be a minor part of the Rigor interface of NM2c and Myo1b18,20. In PfAct1/PfMyoA, the activation Loop (524-539) is not part of the Rigor interface, as is also the case for Myo619. The mean actin/myosin interaction area of all high-resolution Rigor actomyosin structures is 1607.5 Å2 with a standard deviation of 58.1 Å2. Thus, the size of the interface is quite well preserved. Interestingly, almost all the PfAct1 residues that interact with PfMyoA are conserved compared to canonical actins (Supplementary Table 2; Supplementary Fig. 4). The only region of divergence in this footprint is the D-loop. Despite the divergence in sequence of the actomyosin system found in the apicomplexan glideosome, the PfMyoA residues that are part of the interface define a conserved actin footprint.
The footprint is defined by the recognition of a conserved central core interface with less extensive contributions from a more peripheral ancillary interface
The interactions establishing contacts between actin and myosin in the PfAct1/PfMyoA structure were compared to those of other Rigor structures to deduce how the divergent actin-binding loops of distinct myosins accommodate binding to this conserved actin footprint. The conservation of the residues involved in the actomyosin interface has been a subject of debate. Few actomyosin structures are available at a sufficient resolution to confidently deduce the position of residues and interactions made at the interface, and thus a structure fully describing side chain interactions and solvent contribution is still unavailable. However, sufficient differences in main chain loop interactions and some of the side chains defined in cryo-EM maps provide enough information to describe the main features of the Rigor interfaces (PfAct1/PfMyoA described here and in references18–20). The study carried out with Myo6 highlighted the divergence in the interface of this motor compared to previously described actomyosin Rigor complexes19 whereas the study performed on Myo1b described only minor differences with the NM2c interface20. The PfAct1/PfMyoA interface was compared to those of Rigor structures of NM2c, Myo1b and Myo6 after aligning the structures using the F-actin region involved in myosin recognition. This analysis allowed us to distinguish between a large core interface that is common among all four myosins, and a more divergent and ancillary interface (Fig. 4b, c). The core interface, which is essentially completely conserved, is established by the HCM-Loop and most interactions of the HTH, extended by conserved contributions of Loop2. The smaller ancillary interface which is more divergent and established by the HS helix of the HTH, Loop3, Loop4 and, in some cases, additional contributions from the Activation Loop and the strut (Supplementary Table 2). A few additional interactions from Loop 2 and the HW helix may also complete the ancillary interface for some Rigor structures. Interestingly, despite sequence divergence of PfAct1 compared to canonical actin, PfMyoA binds to the actin surface where the sequence is conserved in both actins (Supplementary Table 2). Only two polymorphisms are found in actin and they are located in the ancillary interface. They correspond to a residue that interacts with Loop4 (PfV330, SkI331) with no major impact on the interface and to a sequence difference in the D-loop (PfE49, SkG50).
The conserved core interface of Rigor actomyosin structures
The conserved core interface of the Rigor state corresponds to the largest part of the interface, including interactions on either side of the myosin inner cleft with the interface between the D-loop and subdomains 1 and 3 (SD1, SD3) of the filament (Fig. 4b; Supplementary Table 2A). Most of this interface corresponds to extensive apolar contacts with few specific interactions. Several apolar interactions occur from residues of the HR helix or the turn of the HTH. While the sequence of these residues varies amongst the four myosins, the regions of interaction on the actin filament are conserved. The HTH structural element, the actin binding element most conserved in sequence, comprises two invariably conserved residues that interact with actin in a conserved fashion in all Rigor structures. The first conserved residue is an acidic amino-acid from the HR-helix (D544 in PfMyoA) that establishes polar interactions with a serine of SD1 (S351 in PfAct1, S350 in canonical actin). The second conserved residue is a proline at the tip region of the HTH (P549 in PfMyoA) that plugs into a hydrophobic cavity at the D-loop/SD1 interface between the two neighboring actin monomers. The main actin residues recognizing this HTH turn region belong to SD1 and SD3, close to subdomain 2 (SD2) of the actin below. While less preserved amongst the Rigor structures, residues on either side of this proline in the HTH turn indeed provide additional hydrophobic interactions in the cavity in a lock-and-key fashion (Supplementary Table 2A, Supplementary Fig. 3).
The second part of the core interface involves the HCM-loop, which is a β-hairpin that presents hydrophobic residues that establish contacts with actin via residues lining the cleft between SD1/SD3 on the hydrophobic cleft (Supplementary Table 2A). The number of the HCM-loop residues that interact with F-actin and their sequence have been reported to be variable among myosins19,20. While the PfMyoA HCM-loop residues that contact the PfAct1 filament do not correspond to either of the other myosin sequences, they anchor the HCM-loop in a similar orientation on the actin surface. However, the variability in the nature of these residues greatly influences the exact interface formed. For example, the same negative actin surface residues (E335 in PfAct1, E336 in canonical actin) can either form polar interactions with the first strand of the HCM-loop β-hairpin (PfMyoA, NM2c, Myo1b) or the second strand (Myo6) (Supplementary Table 2A). Another example is the TEDS residue, a consensus site for phosphorylation23 found at the tip of the β-turn, which is either a negatively charged residue (E,D) or one that can be phosphorylated (T,S). In the Rigor structures, this residue only interacts with a positively charged residue on actin when the position is occupied by a glutamate (i.e. Myo1b or the PfMyoA T417D mutant used in this study). Otherwise, there is no interaction of this residue with actin at the Rigor interface.
Lastly, the C-terminal end of Loop2 complements the interaction in the core surface by interacting with a negatively charged patch on SD1 in between the HCM-loop and HTH-turn interfaces (Supplementary Table 2A). Loop2 is the most variable region of the actin binding surface found on myosins—both in size and sequence. Despite this variability, Loop2 binds essentially to the same surface on the SD1 of F-actin and is usually stabilized when binding to F-actin16. As it is the case for Myo1b, PfMyoA has a short Loop2. One common feature among the Myo1b and PfMyoA Rigor complexes is that the interactions formed involve positively charged residues of Loop2, extended to positively charged residues of the strut (Supplementary Table 2A). Although these residues are not conserved in their position (G633 and K634 in PfMyoA), they interact with the same residues of the actin surface (G24, D25, D26 in PfAct1).
The ancillary interface of the Rigor structures
The ancillary interface (Fig. 4c, Supplementary Table 2B) comprises the most variable interactions that are also regions of the interface distal from the main core. This actin-binding surface is composed of residues interacting with the HS helix of the HTH, Loop3, Loop4 and, in some cases, the Activation Loop. The N-terminus of the actin subunits is flexible and often disordered in the Rigor structures, but it may participate in this ancillary interface. This is clearly indicated in the cryo-EM map of the NM2c Rigor structure in which contacts with actin’s N-terminal residue E5 occur via residues of loop2 and the HW helix (Supplementary Table 2B; Supplementary Fig. 5A; Supplementary Fig. 4). All four sites of the ancillary interface differ in the nature of the contacts made among actomyosin structures (Supplementary Fig. 3). (i) Loop3 is highly variable in sequence and in length, but residues of the N-terminal part of its sequence bind the same residues in SD1 although the exact contacts made for the different Rigor myosin interfaces are different (Supplementary Fig. 5B). (ii) Loop4 is also highly variable in sequence and in conformation and has fewer and non-conserved contributions compared to elements that form the core interface (Supplementary Fig. 5C; Supplementary Table 2B). The tip of the loop interacts with SD3 of actin. In the NM2c Rigor complex, there are only minor contacts with SD3 and Loop4 and this region favors interactions with tropomyosin18. It is tempting to speculate that the contribution of Loop4 to binding of the filament is class-dependent and allows specificity in the recognition of the target actin filament as well as tropomyosin interactions. Myo1b is indeed less efficient on actin-tropomyosin filaments and this contributes to the selective localization of this myosin in cells32,33. (iii) The Activation Loop is not part of the Rigor interface of PfAct1/PfMyoA and that of Myo6. Some contributions of this loop to the Rigor interface occur for NM2c and Myo1b although these are relatively minor (Supplementary Table 2B). (iv) Lastly, the HS helix of the HTH motif provides critical interactions with the D-loop and thus can extend the interface close to the core (Supplementary Fig. 5D; Supplementary Fig. 3). In the PfAct1 and canonical actin structures, the D-loop is the structural element that explores the most dynamic structural conformations; and these are influenced by the nucleotide-state of the filament27,28. PfAct1 is divergent from canonical actin in the D-loop conformation and this is also where the main sequence differences of the footprint reside, i.e. the presence of a glutamate (E49) instead of a glycine (G50) found in canonical actin. Interestingly, while most myosins have a negatively charged residue on the HS helix facing G50, the sequence of PfMyoA is a serine (S558) at this position, avoiding some charge repulsion between the residues in contact. Myo6 has also a serine in this position and the conformation described for the D-loop locally differs from that of Myo1b and NM2c, allowing it to optimize contacts with the small serine side chain (Supplementary Table 2B). This D-loop conformation found for a canonical F-actin when bound to Myo6, would not be compatible with the presence in the myosin HS helix sequence of an aspartate or a glutamate. We conclude that the interactions of the HS helix with the D-loop can cause local and possibly important induced fits when the motor and the actin filament interact. This region of the ancillary interface close to the core interface is likely to play an important role in defining how different myosins would be more or less efficient depending on the age of the F-actin filament they are interacting with34.
The ancillary interface determines the position of myosin on F-actin in the absence of nucleotide
The motor positioning on the filament can vary greatly when the cryo-EM Rigor structures are compared. The core interactions are at the center of the interface and are not likely to influence this positioning significantly. In contrast, the ancillary interface probably plays a more important role in positioning. The fact that the lower 50 kDa domain differs in its positioning for PfMyoA compared to the other motors, is likely linked to the interactions that occur between the HS helix and the D-loop, which themselves depend on the conformation and sequence of the D-loop. In the case of Myo6, for which the difference in the lower 50 kDa domain orientation is greater, optimization of interactions with Loop3 is likely to be a key factor.
A closer look at the interface indicates how the core interactions can be conserved despite a rather large difference in the position of the different motors on F-actin. Local adaptation in the conformation of the actin residues near the C-terminus is also likely to optimize the core interactions with the HR-helix. Another key element that may conserve the core interactions involves flexibility in the HCM-loop, which optimizes the orientation of the upper 50 kDa domain to accommodate ancillary interactions with Loop4. The flexibility at the beginning and end of both the HCM-loop and Loop4 are restrained but could be essential for allowing the repositioning of the upper 50 kDa domain resulting in conservation of the footprint and the cleft closure in these different Rigor structures.
Motility assays show similar speeds with various actin and myosin pairs
The finding that canonical actomyosin systems and the divergent P. falciparum actomyosin system share a common interaction footprint was unexpected. To test whether this equivalence in footprints translates to equivalence in functionality, motility assays were performed using PfMyoA and smooth muscle myosin paired with either skeletal muscle actin, smooth muscle actin, or PfAct1 filaments. To allow meaningful comparison, identical setups were used for evaluating motility, i.e. the respective myosin motors were adhered to the coverslip and the speed of unrestrained actin filaments being moved was evaluated. This setup should be insensitive to the differences in twist between canonical actin and PfAct1 filaments.
Interestingly, no difference in speeds were observed when PfMyoA moved JAS-stabilized PfAct1 filaments, skeletal muscle actin or smooth muscle actin. Although JAS has profound effects on the polymerization properties of PfAct113, the PfMyoA motor did not discern a difference when it moved JAS-stabilized versus unstabilized PfAct1 filaments. Likewise, when smooth muscle myosin was paired with JAS-stabilized PfAct1 filaments, skeletal muscle actin, or smooth muscle actin, no difference in speeds were observed (Table 1). These assays demonstrate that PfMyoA moves all actin filaments with essentially identical speed, and that the conventional motor smooth muscle myosin also moves PfAct1 filaments at indistinguishable speeds to how it moves canonical actin filaments. Similarities in the interaction footprint thus translate directly into similarities in motility speeds.
Table 1.
Actin | PfMyoA (µm/s) | Smooth muscle myosin (µm/s) |
---|---|---|
PfAct1/JAS | 3.55 ± 0.53 (n=905) | 0.53 ± 0.19 (n=1441) |
PfAct1 | 3.98 ± 0.67 (n=1545) | n.d. |
Skeletal | 3.85 ± 0.59 (n=942) | 0.62 ± 0.29 (n=953) |
Smooth | 4.21 ± 0.63 (n=1232) | 0.51 ± 0.22 (n=1019) |
Values are mean ± SD. Two separate experiments were performed for each condition. Each pairwise combination of a given motor with different actins is statistically insignificant using a two-sided z-test. All PfMyoA/actin pairs, p ≥ 0.416; all smooth muscle myosin/actin pairs, p ≥ 0.774 (PfMyoA/PfAct1/JAS vs. PfMyoA/PfAct1: p = 0.604; PfMyoA/PfAct1/JAS vs. PfMyoA/skeletal: p = 0.704; PfMyoA/PfAct1/JAS vs. PfMyoA/smooth: p = 0.416; PfMyoA/PfAct1 vs. PfMyoA/skeletal: p = 0.875; PfMyoA/PfAct1 vs. PfMyoA/smooth: p = 0.803; PfMyoA/skeletal vs. PfMyoA/smooth: p = 0.673; Smooth muscle myosin/PfAct1/JAS vs. Smooth muscle myosin/skeletal: p = 0.799; Smooth muscle myosin/PfAct1/JAS vs. Smooth muscle myosin/smooth: p = 0.954; Smooth muscle myosin/skeletal vs. Smooth muscle myosin/smooth; p = 0.774).
Discussion
The binding of PfMyoA to the PfAct1 filament does not induce major conformational changes in the actin filament or in the motor. The cleft closure in the motor is similar to that found for other myosin motors bound to actin18–20 and the Rigor-like crystal structure of PfMyoA8. The D-loop in the bound PfAct1 filament is quite similar to the conformation seen in other Rigor structures, all of which have been reported to have a closed D-loop conformation, consistent with the fact that the motor was bound to ADP F-actin filaments18–20,35,36. The D-loop conformation in PfAct1 filaments does not shift position upon PfMyoA binding, which differs from at least two mammalian actomyosins, namely NM2c and Myo6 in the Rigor state18,19.
The actomyosin interface is composed of a highly conserved actin core extended by more variable ancillary regions. Comparison of currently available high-resolution cryo-EM reconstructions of myosin strongly bound to actin filaments provides insights about the conserved elements in the strong binding states of myosin motors: (i) a conserved motor domain conformation with a specific cleft closure, (ii) a conserved surface on the bound actin filament that participates in interaction with myosin and (iii) an absence of major conformational changes of the filament when binding a motor, although a relative decrease in the dynamics of some filament regions occurs.
Remarkably, the divergence in sequence of PfAct1 compared to canonical actin does not impact residues of the footprint, with the notable exception of the D-loop, which is variable in sequence. Thus, the myosin side of the interface remarkably adapts to recognize the same residues of the footprint, by forming locally distinct interactions. This makes the interface variable in detail, as previously observed19,20, while retaining conserved general principles. Local adaptations on myosin lead to recognition of the same residues on the actin surface for the different myosins. Motility assays support these structural observations by showing that a given myosin motor can move heterologous actins at the same speed as its cognate actin.
The remarkable finding that there are conserved features among Rigor structures spanning the phylogenetic tree from apicomplexans all the way to humans is important for understanding how motors have evolved. Myosins are traditionally classified as members of a superfamily based on phylogenetic analysis of their head domains37. While these types of phylogenetic relationships provide insights into how specific myosin functions are related within and between families, the evolutionary history of myosin is not revealed by such studies. This history can only be assessed by considering the evolution of entire organisms. Except for the structure presented here, all other high-resolution actomyosin structures solved up to now were mammalian.
Myosin is specific to Eukaryotes and does not occur in Bacteria or Archaea. The phylogenic relationship between P. falciparum and mammals is about as distant as it can be within the eukaryotic branch of the phylogenetic tree of life. In the latest super-group model of the tree38, the branch that contains the TSAR (Telonemids, Stramenopiles, Alveolates, and Rhizaria) super-group, which includes P. falciparum (Alveolata), and the one that contains mammals (Amorphea), divide very near the root of the tree. While the exact position of the root is still under debate, it is clear that the common ancestor of P. falciparum and mammals is closely related to the Last Eukaryote Common Ancestor (LECA).
Extensive phylogenetic analysis indicates that the LECA had only two different myosins present in its genome39. The high-resolution structure of P. falciparum actomyosin, in conjunction with the mammalian counterparts, thus gives us the opportunity to infer features of the actomyosin complex and its interactions that were already present in the LECA and have been preserved for over a billion years40. The fact that the core actomyosin interactions are essentially identical in all currently known structures, indicates that they have been already present in this form in the LECA and did not change substantially during evolution since then. It is likely that these core interactions are preserved among all actomyosins. The plethora of myosin families and functions thus is independent of this core interaction and is a consequence of secondary actomyosin interactions governed by the divergent portions of the interface as well as other structural elements within specific myosins that are far removed from the interface.
The common, evolutionary conserved interactions that occur for all Rigor structures, provide an anchoring site of the motor on the actin filament that appears to be independent of myosin type, species and function. Importantly, there is also an ancillary footprint on actin with varying actomyosin interactions; the specificity of track recognition (e.g. selection depending on the tropomyosin bound or depending on the age of the filament) resides in the subtlety of the differences found in this interface. In addition, it is likely that these subtle differences play a role in the evolution of cellular roles of specific myosins, since the time spent in the actin-bound states is critical to define how long a motor stays bound to the filament. Current evidence indicates that the internal rearrangements and the stabilization of the Rigor state by interactions within the motor that involve the N-terminal extension can greatly impact ADP release and the duty ratio for both Myo1b and PfMyoA8,41. It remains to be explored whether the specific variations among Rigor structures are also associated with properties of the motor such as the duty ratio, which for several myosins depends mainly on the ADP release rate. Defining whether possible local changes at the actin interface can tune ADP release will require further investigation.
Methods
Myosin expression and purification
A truncated PfMyoA heavy chain (PlasmoDB ID PF3D7_1342600/ GenBank accession number XM_001350111.1) coding for the motor domain (amino acids 1-K768, PfMD), with a T417D mutation to enhance actin affinity, obtained by PCR using gBlocks gene fragments (Integrated DNA Technologies) with Sf9 cell preferred codons as template. Residue K768 was followed by a Gly-Ser linker and a C-terminal FLAG tag. The PCR product was cloned into the baculovirus transfer vector pAcSG2 (BD Biosciences) to make recombinant virus24. The PfMD construct was co-expressed with the PUNC chaperone in Sf9 cells. Cells were grown for 72 hrs, harvested and lysed by sonication in 10 mM imidazole, pH 7.4, 0.2 M NaCl, 1 mM EGTA, 5 mM MgCl2, 7% (w/v) sucrose, 2 mM DTT, 0.5 mM 4-(2-aminoethyl) benzenesuflonyl fluoride, 5 µg ml−1 leupeptin, 2 mM MgATP. 3 mM MgATP was added prior to a clarifying spin at 200,000 g for 40 min. The supernatant was applied to a FLAG-affinity chromatography (Sigma), the column washed with 10 mM imidazole pH 7.4, 0.2 M NaCl, and 1 mM EGTA and the myosin eluted with the same buffer containing 0.1 mg ml−1 FLAG peptide. Peak myosin fractions were pooled and concentrated using an Amicon centrifugal filter device (Millipore). PfMD was dialyzed versus10 mM imidazole pH 7.4, 10 mM NaCl, 1 mM MgCl2, 1 mM EGTA, I mM NaN3, 1 mM DTT prior to use.
Preparation of JAS-stabilized actin filaments
PfAct1 (PlasmoDB PF3D7_1246200/GenBank accession number XM_001350811.1) followed by a linker and human thymosin-β4 (accession number AAI41977.1) was synthesized using gBlocks gene fragments with Sf9 cell preferred codons and cloned into pAcUW51 for expression in Sf9 cells. The initial Cys residue of actin was not included in the construct because it is not present in the mature, processed protein. The thymosin-β4 gene was separated from the actin gene by a 14-aa linker (ASSGGSGSGGSGGA) to allow the thymosin-β4 enough flexibility to occupy the barbed end binding site on the actin monomer, thus preventing the actin from polymerizing with itself or native Sf9 cell actin. A HIS6 tag was added at the C terminus for purification on a nickel affinity column. The final native residue of actin is Phe, which provides a site for chymotrypsin cleavage to remove the linker, thymosin-β4, and the HIS6 tag completely. PfAct1 monomers were purified on a gel filtration column (Superdex 200 10/300 GL, GE Lifesciences 28990944) equilibrated in 5 mM Tris pH 8.0 at 4 °C, 0.2 M NH4Ac, 0.2 mM CaCl2, 0.2 mM NaATP, 0.5 mM DTT. The peak monomeric fractions were converted to actin-MgATP by incubation with a 2-fold molar excess of MgCl2 and 200 μM EGTA for 10 min at 4 °C. A 1.1-fold molar excess of jasplakinolide (Thermo Fisher J7473) was added to the PfAct1-MgATP, followed by addition of one-tenth volume of a 10× polymerization buffer (100 mM imidazole, pH 7.4, 500 mM KCl, 40 mM MgCl2, 10 mM EGTA, 10 mM DTT), and incubation at 37°C for 1 h. Excess ATP was removed by dialysis versus 10 mM imidazole, pH 7.4, 50 mM KCl, 4 mM MgCl2, 1 mM EGTA, 1 mM DTT.
Optimized sample preparation and image acquisition for cryo-EM
Various PfMyoA constructs were screened in conjunction with Skeletal F-actin, P. falciparum actin 1 (PfAct1) stabilized or not by JAS. These constructs included the full-length protein and the motor domain. In our hands, the best samples were generated when myosin was incubated in solution with the F-actin sample and vitrified within 15 min. Thus, four grids were generated at a time. In general, we applied 5 μl of filamentous actin/myosin solution to plasma cleaned holey carbon grid (C-flats 2/2, Protochips), incubated it for 1 min and manually blotted with filter paper and achieved vitrification by plunging into LN2 cooled, liquified ethane using an in-house designed cryo-plunger.
Screening for the best sample mixture ratios and blotting conditions was performed on a T12 Tecnai Spirit electron microscope (ThermoFisher Scientific) equipped with a 4Kx4K Eagle camera (ThermoFisher Scientific), operated at a voltage of 120 kV. Data sets were acquired on a Titan Krios electron microscope (ThermoFisher Scientific) equipped with an extra-high brightness field emission gun (X-FEG) and operated at a voltage of 300 kV. Although the sample preparation protocol was optimized, we had to screen for usable grids and grid squares manually. Images were recorded with a back-thinned 4 K×4 K Falcon 2 (ThermoFisher Scientific) direct detection camera under minimal dose conditions using the automatic data collection software EPU (ThermoFisher Scientific). Within each selected grid hole, two positions were imaged, each with a total exposure time of 1 s. Seven frames with a total electron dose of ~60 electrons per Å2 were collected. A total of 6073 image stacks were collected in five separate, independent imaging sessions. The nominal magnification of 75,000 corresponds to a pixel size of 1.035 Å. The defocus range of the data sets was 0.7–2.8 μm.
Image processing and reconstruction
Dose weighting and motion correction were applied using MotionCor242 with anisotropic motion correction using 5 × 5 patches. The initial defocus was estimated either using Gctf43 or CTFFIND444, depending on the imaging session. The data was then processed with the helical reconstruction routines in RELION325,45. Briefly, the helices were divided into overlapping boxes that were essentially treated as individual, independent particles (with modified Bayesian prior accounting for constraints implied by helicity) to allow sorting of the segments into different conformations and selecting the most well-defined of the conformations present in the sample, a prerequisite for reaching high resolution. A total of 509,035 filament segments were extracted using a box size of 336 × 336 pixels from 41,940 manually picked filaments. Two-dimensional reference-free classification for the data set was carried out in RELION3 to eliminate bad segments reducing the number of segments from 509,035 to 464,646. As an initial model, an in-house rabbit skeletal actin reconstruction filtered to 40-Å resolution was used. An initial reconstruction at 5.1 Å showing clear and detailed density for PfMyoA was obtained. After several rounds of 3D classification and refinement followed by manual removal of bad particles and careful enrichment of segments showing clear decoration using the initial reconstruction as a reference, the estimated resolution of the reconstruction reached 3.8 Å after processing using the 0.143 FSC cutoff gold-standard procedure implemented in RELION3. The processing included RELION3-based CTF refinement, B-factor sharpening, and application of a soft-edged mask generated in RELION3 corrected for helical edge effects using pyCoAn, an extended python version of CoAn46. Additional sharpening was applied using the auto-sharpening routine in Phenix47,48. The reconstruction was then symmetrized within pyCoAn using the helical parameters refined by RELION3. Local resolution estimates were calculated with ResMap49.
Model building and refinement
The atomic models of the PfAct1 filament stabilized by JAS (PDB code 5OGW; https://www.rcsb.org/structure/5OGW) and PfMyoA in the Rigor-like state (PDB code 6I7D chain D; https://www.rcsb.org/structure/6I7D) as starting points. The models were independently fitted into the map with the function “fit in map” in UCSF Chimera50. Building of Loop2 and manual refinement of the model was performed with Coot51. A first step of real space refinement was performed with Phenix48. In order to improve the statistics at the interface and to compute realistic interactions, we performed an independent run of molecular dynamics. The system was built with the CHARMM-GUI52,53, using the Quick MD Simulator module. Only the actin binding elements of PfMyoA and surfaces of the PfAct1 filament interacting with PfMyoA were relaxed in a box containing explicit water (TIP3P) and salt (150 mM KCl) in the CHARMM36 force field, the rest of the model being fixed during all the duration of the simulation. The duration of the simulation was 10 ns in GROMACS (version 5.1.4)54. The output of the simulation was then submitted to another run of real space refinement. A final run of reciprocal space refinement was performed with Refmac55. To improve the overall consistency between the models used for comparison, the published models of the Myo6 and Myo1b Rigor states were subjected to reciprocal space refinement with Refmac. Quality indicators, including MolProbity56 and EMRinger57 scores, were calculated with Phenix. The additional refinement step improved the EMRinger score of Myo6 from 0.11 to 0.36 and the EMRinger score of Myo1b from 1.41 to 1.68. The Rigor state of NM2c was already refined with Refmac so the additional step was not necessary for that model.
Interface analysis
All the actomyosin interfaces were analyzed automatically with the software PDBsum58 for protein-protein interfaces. The automatic analysis was complemented by a manual analysis to check long-range interactions with a cut-off of 4 Å. Areas of interaction were calculated with PISA59.
Motility assays
For ensemble motility assays with PfMyoA and phosphorylated smooth muscle myosin, MgATP insensitive heads were removed by a 20 min spin at 350,000 g in the presence of 1.5 mM MgATP and a three-fold molar excess of actin. Myosin concentrations were determined using the Bio-Rad Protein assay. For PfMyoA motility assays, the following solutions were added to a nitrocellulose-coated flow cell in 15 µl volumes. 0.5 mg/ml biotinylated bovine serum albumin (BSA) in buffer A (100 mM KCl, 25 mM imidazole pH 7.5, 1 mM EGTA, 4 mM MgCl2, and 10 mM DTT) was added and incubated for 1 min. Three additions of 5.0 mg ml−1 BSA in buffer A were followed by a 2 min wait. 25 µg ml−1 neutravidin (Thermo Fischer Scientific) in buffer A was added for 1 min and then rinsed three times with buffer A. 120 µg/ml PfMyoA with a C-terminal biotin tag24 was flowed into the cell and incubated for 1 min followed by 3 rinses with buffer A. Skeletal, smooth60 and JAS stabilized PfAct1 filaments were incubated for 30 s followed by one rinse with buffer A and one rinse with buffer B (buffer A plus chromobody, 0.5% (w/v) methylcellulose, 25 µg ml−1 PfELC and 25 µg ml−1 PfMTIP and oxygen scavengers (50 µg ml−1 catalase (Sigma), 125 µg ml−1 glucose oxidase (Sigma), and 3 mg ml−1 glucose). 50 nM chromobody was used to visualize skeletal and smooth actins; 20 nM chromobody was used for PfAct1 filaments. Motility was initiated by adding buffer B containing 2 mM MgATP twice to the flow cell, followed by a 1 min wait for temperature to equilibrate to 30 °C on the microscope. Unstabilized PfAct1 filaments (freshly prepared for each experiment by polymerizing at 8 µM for 10 min at 37 °C), to which 20 nM actin chromobody and 2 mM MgATP were added, was directly loaded into the flow cell with no subsequent washes.
Full-length phosphorylated smooth muscle myosin60 was directly adhered to the nitrocellulose-coated coverslip. 15 µl of 100 µg ml−1 myosin in 300 mM KCl buffer C (25 mM imidazole pH 7.5, 1 mM EGTA, 4 mM MgCl2, and 10 mM DTT) was flowed into the cell and incubated for 1 min. Three 15 µl additions of 5.0 mg ml−1 BSA in 300 mM KCl buffer C were followed by a 2 min wait, and then three 15 µl rinses with 25 mM KCl buffer C. Skeletal, smooth and JAS stabilized PfAct1 filaments were incubated for 30 s followed by three 15 µl rinses with 90 mM KCl buffer C. Next, one rinse of buffer D (90 mM buffer C plus chromobody, 0.7% (w/v) methylcellulose, oxygen scavengers (50 µg ml−1 catalase (Sigma), 125 µg ml−1 glucose oxidase (Sigma), and 3 mg ml−1 glucose). 50 nM chromobody was used to visualize skeletal and smooth actins; 20 nM chromobody was used for PfAct1 filaments. Motility was initiated by adding buffer D containing 1 mM MgATP twice to the flow cell and waiting 1 min for temperature to equilibrate to 30 °C on the microscope. Unstabilized PfAct1 filaments (freshly prepared for each experiment by polymerizing at 8 µM for 10 min at 37 °C), to which 20 nM actin chromobody and 1 mM MgATP were added, was directly loaded into the flow cell with no subsequent washes. Filaments were automatically tracked and analyzed with the Fast Automated Spud Trekker analysis program (FAST, Spudich laboratory, Stanford University, http://spudlab.stanford.edu/fast-for-automatic-motility-measurements). Reported speeds are from a fit to a Gaussian curve. To assess the significance of differences in speed, a two-tailed z-test was chosen because it is ideal for determining whether two population means are different when the variances are similar, and the sample size is large. Samples were assumed to be independent of one another and the populations from which the samples were taken were assumed to be normally distributed. Actin filaments were visualized using a Nikon ECLIPSE Ti microscope.
Reporting summary
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Supplementary information
Acknowledgements
This work was supported by National Institutes of Health multi-PI grant AI 132378 to K.M.T, A.H, N.V. and D.H. NIH grants S10-OD012372, S10-OD026926, and PEW innovative funds grant 864K625 (to D.H.) funded the purchase of the Titan Krios electron cryo-microscope (FEI/Thermo Fisher) and Falcon II direct detector (FEI/Thermo Fisher), as well as software and hardware upgrades for both the T12 and Titan including a CMOS Eagle imaging device for the T12. We are grateful to Jean-Louis Rouet and Yohann Brossard of the CaSciModOT service (Calcul Scientifique et Modélisation Orléans-Tours) for their precious technical support and the access to the machines.
Author contributions
K.T., A.H., N.V. and D.H. designed research; J.P.R and H.L performed motility assays; P.M.F. and E.B.K expressed and purified the Plasmodium proteins; X-P.X., M.F.S., N.V. and D.H. generated the cryo-EM data and reconstructions; J.R.P. and D.A. built the model with N.V., J.R.P. and A.H. analyzed the interface, and J.R.P. X-P.X., K.T., A.H., N.V. and D.H analyzed data; J.R.P., K.T., A.H., N.V. and D.H. wrote the paper.
Data availability
Data supporting the findings of this manuscript are available from the corresponding authors upon reasonable request. A reporting summary for this Article is available as a Supplementary Information file. The atomic models and cryo-EM maps are available in the PDB61 and EMDB databases62, under accession numbers 7ALN and EMD-11818 respectively.
Competing interests
The authors declare no competing interests.
Footnotes
Peer review information Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Anne Houdusse, Email: anne.houdusse@curie.fr.
Niels Volkmann, Email: niels.volkmann@pasteur.fr.
Supplementary information
The online version contains supplementary material available at 10.1038/s41467-021-22093-4.
References
- 1.World malaria report 2020: 20 years of global progress and challenges (World Health Organization, Geneva, 2020).
- 2.Haldar K, Bhattacharjee S, Safeukui I. Drug resistance in Plasmodium. Nat. Rev. Microbiol. 2018;16:156–170. doi: 10.1038/nrmicro.2017.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Frénal K, Dubremetz JF, Lebrun M, Soldati-Favre D. Gliding motility powers invasion and egress in Apicomplexa. Nat. Rev. Microbiol. 2017;15:645–660. doi: 10.1038/nrmicro.2017.86. [DOI] [PubMed] [Google Scholar]
- 4.Tardieux I, Baum J. Reassessing the mechanics of parasite motility and host-cell invasion. J. Cell Biol. 2016;214:507–515. doi: 10.1083/jcb.201605100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Siden-Kiamos I, et al. Stage-specific depletion of myosin A supports an essential role in motility of malarial ookinetes. Cell Microbiol. 2011;13:1996–2006. doi: 10.1111/j.1462-5822.2011.01686.x. [DOI] [PubMed] [Google Scholar]
- 6.Moussaoui, D. et al. Full-length Plasmodium falciparum myosin A and essential light chain PfELC structures provide new anti-malarial targets. Elife9, e60581 (2020). [DOI] [PMC free article] [PubMed]
- 7.Blake TCA, Haase S, Baum J. Actomyosin forces and the energetics of red blood cell invasion by the malaria parasite Plasmodium falciparum. PLoS Pathog. 2020;16:e1009007. doi: 10.1371/journal.ppat.1009007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Robert-Paganin J, et al. Plasmodium myosin A drives parasite invasion by an atypical force generating mechanism. Nat. Commun. 2019;10:3286. doi: 10.1038/s41467-019-11120-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Powell CJ, et al. Structural and mechanistic insights into the function of the unconventional class XIV myosin MyoA from Toxoplasma gondii. Proc. Natl Acad. Sci. USA. 2018;115:E10548–E10555. doi: 10.1073/pnas.1811167115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Vahokoski J, et al. Structural differences explain diverse functions of Plasmodium actins. PLoS Pathog. 2014;10:e1004091. doi: 10.1371/journal.ppat.1004091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Pospich S, et al. Near-atomic structure of jasplakinolide-stabilized malaria parasite F-actin reveals the structural basis of filament instability. Proc. Natl Acad. Sci. USA. 2017;114:10636–10641. doi: 10.1073/pnas.1707506114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kumpula EP, Lopez AJ, Tajedin L, Han H, Kursula I. Atomic view into Plasmodium actin polymerization, ATP hydrolysis, and fragmentation. PLoS Biol. 2019;17:e3000315. doi: 10.1371/journal.pbio.3000315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lu H, Fagnant PM, Trybus KM. Unusual dynamics of the divergent malaria parasite PfAct1 actin filament. Proc. Natl Acad. Sci. USA. 2019;116:20418–20427. doi: 10.1073/pnas.1906600116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rayment I, et al. Structure of the actin-myosin complex and its implications for muscle contraction. Science. 1993;261:58–65. doi: 10.1126/science.8316858. [DOI] [PubMed] [Google Scholar]
- 15.Schröder RR, et al. Three-dimensional atomic model of F-actin decorated with Dictyostelium myosin S1. Nature. 1993;364:171–174. doi: 10.1038/364171a0. [DOI] [PubMed] [Google Scholar]
- 16.Volkmann N, et al. Evidence for cleft closure in actomyosin upon ADP release. Nat. Struct. Biol. 2000;7:1147–1155. doi: 10.1038/82008. [DOI] [PubMed] [Google Scholar]
- 17.Behrmann E, et al. Structure of the rigor actin-tropomyosin-myosin complex. Cell. 2012;150:327–338. doi: 10.1016/j.cell.2012.05.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.von der Ecken J, Heissler SM, Pathan-Chhatbar S, Manstein DJ, Raunser S. Cryo-EM structure of a human cytoplasmic actomyosin complex at near-atomic resolution. Nature. 2016;534:724–728. doi: 10.1038/nature18295. [DOI] [PubMed] [Google Scholar]
- 19.Gurel, P. S. et al. Cryo-EM structures reveal specialization at the myosin VI-actin interface and a mechanism of force sensitivity. Elife6 (2017). [DOI] [PMC free article] [PubMed]
- 20.Mentes A, et al. High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. Proc. Natl Acad. Sci. USA. 2018;115:1292–1297. doi: 10.1073/pnas.1718316115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Robert-Paganin J, Pylypenko O, Kikuti C, Sweeney HL, Houdusse A. Force generation by myosin motors: a structural perspective. Chem. Rev. 2020;120:5–35. doi: 10.1021/acs.chemrev.9b00264. [DOI] [PubMed] [Google Scholar]
- 22.Schmitz S, et al. Malaria parasite actin polymerization and filament structure. J. Biol. Chem. 2010;285:36577–36585. doi: 10.1074/jbc.M110.142638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bement WM, Mooseker MS. TEDS rule: a molecular rationale for differential regulation of myosins by phosphorylation of the heavy chain head. Cell Motil. Cytoskeleton. 1995;31:87–92. doi: 10.1002/cm.970310202. [DOI] [PubMed] [Google Scholar]
- 24.Bookwalter CS, et al. Reconstitution of the core of the malaria parasite glideosome with recombinantPlasmodiumclass XIV myosin A and Plasmodiumactin. J. Biol. Chem. 2017;292:19290–19303. doi: 10.1074/jbc.M117.813972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.He S, Scheres SHW. Helical reconstruction in RELION. J. Struct. Biol. 2017;198:163–176. doi: 10.1016/j.jsb.2017.02.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wulf SF, et al. Force-producing ADP state of myosin bound to actin. Proc. Natl Acad. Sci. USA. 2016;113:E1844–E1852. doi: 10.1073/pnas.1516598113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Merino F, et al. Structural transitions of F-actin upon ATP hydrolysis at near-atomic resolution revealed by cryo-EM. Nat. Struct. Mol. Biol. 2018;25:528–537. doi: 10.1038/s41594-018-0074-0. [DOI] [PubMed] [Google Scholar]
- 28.Pospich S, Merino F, Raunser S. Structural effects and functional implications of phalloidin and jasplakinolide binding to actin filaments. Structure. 2020;28:437–449. doi: 10.1016/j.str.2020.01.014. [DOI] [PubMed] [Google Scholar]
- 29.Chou SZ, Pollard TD. Mechanism of actin polymerization revealed by cryo-EM structures of actin filaments with three different bound nucleotides. Proc. Natl Acad. Sci. USA. 2019;116:4265–4274. doi: 10.1073/pnas.1807028115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.von der Ecken J, et al. Structure of the F-actin–tropomyosin complex. Nature. 2014;519:114–117. doi: 10.1038/nature14033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ren Z, et al. Cryo-EM structure of actin filaments from Zea mays pollen. Plant Cell. 2019;31:2855–2867. doi: 10.1105/tpc.18.00973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Tang N, Ostap EM. Motor domain-dependent localization of myo1b (myr-1) Curr. Biol. 2001;11:1131–1135. doi: 10.1016/S0960-9822(01)00320-7. [DOI] [PubMed] [Google Scholar]
- 33.Ostap EM. Tropomyosins as discriminators of myosin function. Adv. Exp. Med Biol. 2008;644:273–282. doi: 10.1007/978-0-387-85766-4_20. [DOI] [PubMed] [Google Scholar]
- 34.Zimmermann D, Santos A, Kovar DR, Rock RS. Actin age orchestrates myosin-5 and myosin-6 run lengths. Curr. Biol. 2015;25:2057–2062. doi: 10.1016/j.cub.2015.06.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fujii T, Namba K. Structure of actomyosin rigour complex at 5.2 Å resolution and insights into the ATPase cycle mechanism. Nat. Commun. 2017;8:13969. doi: 10.1038/ncomms13969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Banerjee C, et al. The structure of the actin-smooth muscle myosin motor domain complex in the rigor state. J. Struct. Biol. 2017;200:325–333. doi: 10.1016/j.jsb.2017.10.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Cope MJT, Whisstock J, Rayment I, Kendrick-Jones J. Conservation within the myosin motor domain: implications for structure and function. Structure. 1996;4:969–987. doi: 10.1016/S0969-2126(96)00103-7. [DOI] [PubMed] [Google Scholar]
- 38.Burki F, Roger AJ, Brown MW, Simpson AGB. The new tree of eukaryotes. Trends Ecol. Evol. 2020;35:43–55. doi: 10.1016/j.tree.2019.08.008. [DOI] [PubMed] [Google Scholar]
- 39.Kollmar M, Mühlhausen S. Myosin repertoire expansion coincides with eukaryotic diversification in the Mesoproterozoic era. BMC Evolut. Biol. 2017;17:211–229. doi: 10.1186/s12862-017-1056-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Koumandou VL, et al. Molecular paleontology and complexity in the last eukaryotic common ancestor. Crit. Rev. Biochem Mol. Biol. 2013;48:373–396. doi: 10.3109/10409238.2013.821444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Greenberg MJ, Lin T, Shuman H, Ostap EM. Mechanochemical tuning of myosin-I by the N-terminal region. Proc. Natl Acad. Sci. USA. 2015;112:E3337–E3344. doi: 10.1073/pnas.1506633112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zheng SQ, et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods. 2017;14:331–332. doi: 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Zhang K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 2016;193:1–12. doi: 10.1016/j.jsb.2015.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rohou A, Grigorieff N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015;192:216–221. doi: 10.1016/j.jsb.2015.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife7, e42166 (2018). [DOI] [PMC free article] [PubMed]
- 46.Volkmann N, Hanein D. Quantitative fitting of atomic models into observed densities derived by electron microscopy. J. Struct. Biol. 1999;125:176–184. doi: 10.1006/jsbi.1998.4074. [DOI] [PubMed] [Google Scholar]
- 47.Terwilliger TC, Sobolev OV, Afonine PV, Adams PD. Automated map sharpening by maximization of detail and connectivity. Acta Crystallogr D. Struct. Biol. 2018;74:545–559. doi: 10.1107/S2059798318004655. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Liebschner D, et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Cryst. D. 2019;75:861–877. doi: 10.1107/S2059798319011471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kucukelbir A, Sigworth FJ, Tagare HD. Quantifying the local resolution of cryo-EM density maps. Nat. Methods. 2014;11:63–65. doi: 10.1038/nmeth.2727. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Goddard TD, Huang CC, Ferrin TE. Visualizing density maps with UCSF Chimera. J. Struct. Biol. 2007;157:281–287. doi: 10.1016/j.jsb.2006.06.010. [DOI] [PubMed] [Google Scholar]
- 51.Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr. 2010;66:486–501. doi: 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput Chem. 2008;29:1859–1865. doi: 10.1002/jcc.20945. [DOI] [PubMed] [Google Scholar]
- 53.Brooks BR, et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 2009;30:1545–1614. doi: 10.1002/jcc.21287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Abraham MJ, et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:9–25. doi: 10.1016/j.softx.2015.06.001. [DOI] [Google Scholar]
- 55.Kovalevskiy O, Nicholls RA, Long F, Carlon A, Murshudov GN. Overview of refinement procedures within REFMAC5: utilizing data from different sources. Acta Crystallogr D. Struct. Biol. 2018;74:215–227. doi: 10.1107/S2059798318000979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Chen VB, et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr. 2010;66:12–21. doi: 10.1107/S0907444909042073. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Barad BA, et al. EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy. Nat. Methods. 2015;12:943–946. doi: 10.1038/nmeth.3541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Laskowski RA, et al. PDBsum: a Web-based database of summaries and analyses of all PDB structures. Trends Biochem. Sci. 1997;22:488–490. doi: 10.1016/S0968-0004(97)01140-7. [DOI] [PubMed] [Google Scholar]
- 59.Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022. [DOI] [PubMed] [Google Scholar]
- 60.Lu H, Fagnant PM, Bookwalter CS, Joel P, Trybus KM. Vascular disease-causing mutation R258C in ACTA2 disrupts actin dynamics and interaction with myosin. Proc. Natl Acad. Sci. USA. 2015;112:E4168–E4177. doi: 10.1073/pnas.1507587112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Burley SK. Integrative/hybrid methods structural biology: role of macromolecular crystallography. Adv. Exp. Med Biol. 2018;1105:11–18. doi: 10.1007/978-981-13-2200-6_2. [DOI] [PubMed] [Google Scholar]
- 62.Lawson CL, et al. EMDataBank unified data resource for 3DEM. Nucleic Acids Res. 2016;44:D396–D403. doi: 10.1093/nar/gkv1126. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data supporting the findings of this manuscript are available from the corresponding authors upon reasonable request. A reporting summary for this Article is available as a Supplementary Information file. The atomic models and cryo-EM maps are available in the PDB61 and EMDB databases62, under accession numbers 7ALN and EMD-11818 respectively.